Skip to main content
DAVITA INC. logo

DAVITA INC. — Investor Relations & Filings

Ticker · DVA ISIN · US23918K1088 LEI · M2XHYMU3TZNEZURC6H66 US Human health and social work activities
Open in API
Filings indexed 2,061 across all filing types
Latest filing 2017-12-12 Director's Dealing
Country US United States of America
Listing US DVA

About DAVITA INC.

https://www.davita.com/

DaVita Inc. is a healthcare provider specializing in kidney care services. The company offers a range of treatments for patients with chronic kidney disease and end-stage kidney disease, primarily through a network of outpatient dialysis centers. Its core service is providing life-sustaining dialysis, including in-center hemodialysis and peritoneal dialysis. In addition to clinical treatments, DaVita provides integrated health care management and extensive patient support. This includes educational resources, tools, and dietary guidance to help individuals manage their kidney health throughout their entire disease journey. The company focuses on delivering holistic and equitable care to improve the quality of life for its patients.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2017-12-12 English
8-K
Regulatory Filings Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement, specifically an Equity Purchase Agreement for the sale of a business division. It details the terms of the transaction, conditions, and expected closing timeline. There are no financial statements or detailed financial performance data included, only a description of the transaction and related agreements. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a significant corporate event but not a full financial report or earnings release.
2017-12-06 English
10-Q
Interim / Quarterly Report Q3 2017
2017-11-07 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by DaVita Inc. It announces the company's financial results for the three and nine months ended September 30, 2017, and includes a press release as an exhibit. The text explicitly states that the press release announces financial results, which corresponds to an Earnings Release. The document length is 3621 characters, which is relatively short and typical for an 8-K earnings announcement. There is no detailed financial data or comprehensive financial statements included, only a summary announcement. Therefore, this document is best classified as an Earnings Release (ER).
2017-11-07 English
8-K
Transaction in Own Shares Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated October 10, 2017, by DaVita Inc. The content focuses on the announcement of an increase in the authorization under the company's share repurchase program. It details the terms and conditions of the repurchase program but does not contain financial statements or detailed financial analysis. The document is about a share repurchase program update, which is a capital structure change. Given the nature of the announcement about share repurchase authorization, it fits the category of Transaction in Own Shares (POS). The document length is 5386 characters, which is sufficient for a detailed announcement but not a full financial report. Therefore, the classification is POS with high confidence.
2017-10-10 English
FORM 4
Director's Dealing
2017-10-03 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.